COMP <GO>
EMR vs FXHO // DIVIDEND YIELD & FCF PAYOUT SAFETY
Emerson Electric Company (NYSE) VS. UTime Limited (Class A) (NASDAQ) • 15-METRIC TALLY: EMR 9
— FXHO 0
▲ DIVIDEND YIELD & FCF PAYOUT SAFETY LEADER: EMR
LAST: $164.94 (-3.40%) • MKT CAP: $95.24B
dividend-safety
1.25%
LAST: $5.77 (-15.52%) • MKT CAP: $193.1M
dividend-safety
0.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (EMR VS. FXHO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | EMR | FXHO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 52.80% | 1.00% | +51.80 | EMR | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.70% | — | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | 30.9x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 2.80% | -10.98% | +13.78 | EMR | /fcf-yield <GO> |
| Operating Margin | 15.50% | -11.10% | +26.60 | EMR | /operating-margins <GO> |
| Net Profit Margin | 12.70% | -14.20% | +26.90 | EMR | /net-margins <GO> |
| Revenue Growth (YoY) | 3.00% | -17.70% | +20.70 | EMR | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety ACTIVE | 1.25% | 0.00% | +1.25 | EMR | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.80 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 1/9 | +6.00 | EMR | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 64.1 | 39.7 | +24.40 | EMR | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.34 | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 38.6x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $95.24B | $193.1M | $95.05B | EMR | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | EMR REV | FXHO REV | EMR GROSS % | FXHO GROSS % | EMR FCF | FXHO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $18.02B | $28.5M | 52.8% | 1.0% | $2.67B | -$21.2M |
| FY 2024 | $17.49B | $34.6M | 50.8% | 2.8% | $2.91B | -$4.4M |
| FY 2023 | $15.16B | $24.3M | — | — | -$45.4M | -$53.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
EMR // BETA 1.34
FXHO // BETA —